Snakebite envenomation remains a critical global health challenge, particularly in tropical and subtropical regions where access to timely treatment is limited. Advances in monovalent antivenom, antivenom production, and venom immunotherapy are reshaping therapeutic approaches and improving survival outcomes. Within this evolving landscape, the Snake Antivenom Market is...